Put two biotech company and two industry leaders in the same room. Throw in a doctor turned venture capital investor. Ask a few questions.
What happens? A 60-minute discussion of the current state of biotechnology, its challenges and its opportunities. The event is transcribed in this month's Business North Carolina magazine, and recorded as a podcast for the Biotechnology Center Web site.
Arthur O. Murray, Business North Carolina's managing editor for special projects, moderated the event that included:
- Vipin Garg, President and Chief Executive Officer of Tranzyme Pharma
- Chris Kroeger, Partner at Aurora Funds
- Samuel Taylor, President of the North Carolina Biosciences Organization
- Norris Tolson, President and Chief Executive Officer of the North Carolina Biotechnology Center
- Sarah Yocum, Chief Executive Officer of Aqualutions Inc.
Podcast
Part 1 - The state of biotechnology in North Carolina, attracting new and growing existing businesses and facilitating technology transfer.
Part 2 - Filling jobs, cultivating talent, and facing international competition.